Seeking Alpha · 市场快讯·· 7 天前AI 评分37
Kalaris Therapeutics, Inc. Q3 GAAP EPS of -$0.46 beats by $0.05
Kalaris Therapeutics, Inc. GAAP EPS of -$0.46 beats by $0.05
AI 导读
Kalaris Therapeutics, Inc. Q3 GAAP EPS of -$0.46 beats by $0.05. As of September 30, 2026, the company had cash, cash equivalents and marketable securities of $82.9M.
来源:Seeking Alpha · 市场快讯 · seekingalpha.com